JPS5753449A - 2-hydroxy-5-phenylazobenzoic acid derivative, manufacture and medicinal composition - Google Patents
2-hydroxy-5-phenylazobenzoic acid derivative, manufacture and medicinal compositionInfo
- Publication number
- JPS5753449A JPS5753449A JP56111534A JP11153481A JPS5753449A JP S5753449 A JPS5753449 A JP S5753449A JP 56111534 A JP56111534 A JP 56111534A JP 11153481 A JP11153481 A JP 11153481A JP S5753449 A JPS5753449 A JP S5753449A
- Authority
- JP
- Japan
- Prior art keywords
- hydroxy
- manufacture
- acid derivative
- medicinal composition
- phenylazobenzoic acid
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C245/00—Compounds containing chains of at least two nitrogen atoms with at least one nitrogen-to-nitrogen multiple bond
- C07C245/02—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides
- C07C245/06—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings
- C07C245/08—Azo compounds, i.e. compounds having the free valencies of —N=N— groups attached to different atoms, e.g. diazohydroxides with nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings with the two nitrogen atoms of azo groups bound to carbon atoms of six-membered aromatic rings, e.g. azobenzene
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- C—CHEMISTRY; METALLURGY
- C09—DYES; PAINTS; POLISHES; NATURAL RESINS; ADHESIVES; COMPOSITIONS NOT OTHERWISE PROVIDED FOR; APPLICATIONS OF MATERIALS NOT OTHERWISE PROVIDED FOR
- C09B—ORGANIC DYES OR CLOSELY-RELATED COMPOUNDS FOR PRODUCING DYES, e.g. PIGMENTS; MORDANTS; LAKES
- C09B29/00—Monoazo dyes prepared by diazotising and coupling
- C09B29/10—Monoazo dyes prepared by diazotising and coupling from coupling components containing hydroxy as the only directing group
- C09B29/12—Monoazo dyes prepared by diazotising and coupling from coupling components containing hydroxy as the only directing group of the benzene series
- C09B29/14—Hydroxy carboxylic acids
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB8023826 | 1980-07-21 |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5753449A true JPS5753449A (en) | 1982-03-30 |
JPS6225656B2 JPS6225656B2 (ja) | 1987-06-04 |
Family
ID=10514924
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP56111534A Granted JPS5753449A (en) | 1980-07-21 | 1981-07-16 | 2-hydroxy-5-phenylazobenzoic acid derivative, manufacture and medicinal composition |
Country Status (8)
Country | Link |
---|---|
US (1) | US4412992A (ja) |
JP (1) | JPS5753449A (ja) |
DE (1) | DE3128819A1 (ja) |
FR (1) | FR2493312A1 (ja) |
HK (1) | HK31885A (ja) |
IT (1) | IT1138450B (ja) |
MY (1) | MY8600029A (ja) |
SG (1) | SG6885G (ja) |
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02242915A (ja) * | 1988-12-09 | 1990-09-27 | Hoechst Celanese Corp | 改良されたポリエステルコポリマー繊維及びその製造方法 |
JP2004507521A (ja) * | 2000-08-29 | 2004-03-11 | ノベックス・コーポレイション | 抗炎症活性および抗生物質活性を有する5−asa誘導体およびこれを用いて疾患を治療する方法 |
JP2010509326A (ja) * | 2006-11-03 | 2010-03-25 | サリックス ファーマシューティカルズ, インコーポレイテッド | 2−ヒドロキシ−5−フェニル安息香酸誘導体の処方および使用 |
US9192616B2 (en) | 2005-08-24 | 2015-11-24 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
Families Citing this family (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4960765A (en) * | 1980-03-20 | 1990-10-02 | Farmaceutisk Laboratorium Ferring A/S | Pharmaceutical composition and method for the treatment of colitis ulcerosa and Crohn's disease by oral administration |
WO1981002671A1 (en) * | 1980-03-20 | 1981-10-01 | Ferring Farma Lab | Pharmaceutical composition and method for the treatment of colitis ulcerosa and crohn's disease by oral administration |
EP0039306B1 (de) * | 1980-03-28 | 1984-01-11 | Ciba-Geigy Ag | Neue Azofarbstoffe, Verfahren zu deren Herstellung und deren Verwendung |
SE8405924L (sv) * | 1984-11-23 | 1986-05-24 | Pharmacia Ab | Nya azoforeningar |
US5064637A (en) * | 1989-05-30 | 1991-11-12 | Board Of Regents, The University Of Texas System | Substituted sulfonamide derivatives which inhibit allergic reactions |
JPH0586844U (ja) * | 1992-05-01 | 1993-11-22 | 株式会社柴崎製作所 | ピルファープルーフキャップ |
US5498608A (en) * | 1994-01-07 | 1996-03-12 | Salix Pharmaceuticals | Use of 2-hydroxy-5-phenylazobenzoic acid derivatives as colon cancer chemopreventative and chemotherapeutic agents |
SE9700934D0 (sv) | 1997-03-14 | 1997-03-14 | Astra Ab | New formulation |
US6114382A (en) * | 1998-11-11 | 2000-09-05 | Moretti; Itagiba G. | Methods for treating inflammatory bowel disease |
ES2254470T3 (es) * | 2000-08-29 | 2006-06-16 | Nobex Corporation | Compuestos inmunorreguladores, derivados de los mismos y su uso. |
CA2359812C (en) * | 2000-11-20 | 2004-02-10 | The Procter & Gamble Company | Pharmaceutical dosage form with multiple coatings for reduced impact of coating fractures |
US8048924B2 (en) | 2001-08-29 | 2011-11-01 | Biocon Limited | Methods and compositions employing 4-aminophenylacetic acid compounds |
JP2007520495A (ja) | 2004-02-06 | 2007-07-26 | ボロディー トーマス ユリウス | 下痢型過敏性腸症候群におけるアミノサリチル酸の使用法 |
ES2687039T3 (es) * | 2004-03-23 | 2018-10-23 | Biocon Limited | Métodos y composiciones que emplean compuestos de ácido 4-aminofenilacético |
KR20130028807A (ko) * | 2004-05-28 | 2013-03-19 | 샐릭스 파마슈티컬스 인코포레이티드 | 방사선 유발성 장염의 예방, 치료 및 개선 방법 |
HUE028158T2 (en) | 2004-07-07 | 2016-12-28 | Biocon Ltd | Synthesis of bound immunoregulatory compounds |
WO2006125293A1 (en) | 2005-05-27 | 2006-11-30 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
US7741359B2 (en) * | 2005-05-27 | 2010-06-22 | Antibe Therapeutics Inc. | Hydrogen sulfide derivatives of non-steroidal anti-inflammatory drugs |
US7498355B2 (en) * | 2005-05-27 | 2009-03-03 | Antibe Therapeutics Inc. | Derivatives of 4- or 5-aminosalicylic acid |
EP1931354A4 (en) * | 2005-08-24 | 2010-03-24 | Salix Pharmaceuticals Inc | BALSAL ACID FORMULATIONS AND THEIR PREPARATION AND USE |
CN101489986A (zh) * | 2006-06-06 | 2009-07-22 | 安泰碧治疗公司 | 曲美布汀和n-去甲基曲美布汀的盐 |
US7271253B1 (en) | 2006-08-10 | 2007-09-18 | Apotex Pharmachem Inc. | Safe process for the preparation of balsalazide |
KR20100096101A (ko) | 2007-10-19 | 2010-09-01 | 더 보드 오브 리전츠 오브 더 유니버시티 오브 텍사스 시스템 | 박테리아 독성을 억제하는 방법 및 이에 대한 화합물 |
WO2014037832A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment of epilepsy and neurological diseases |
CN102627624B (zh) * | 2012-04-25 | 2014-03-19 | 西南大学 | 4-(4-氨基苯磺酰胺基)苯乙酸衍生物及其制备方法和应用 |
AU2013257742A1 (en) | 2012-05-07 | 2014-11-27 | Cellixbio Private Limited | Compositions and methods for treatment of neuromuscular disorders and neurodegenerative disorders |
JP2015519333A (ja) | 2012-05-07 | 2015-07-09 | セリックスビオ プライヴェート リミテッド | 神経疾患の治療のための組成物および方法 |
WO2013167990A1 (en) | 2012-05-07 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of depression |
US9434704B2 (en) | 2012-05-08 | 2016-09-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological degenerative disorders |
WO2013168025A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of blood clotting disorders |
US9403826B2 (en) | 2012-05-08 | 2016-08-02 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory disorders |
WO2013167991A1 (en) | 2012-05-08 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic disorders |
US9266823B2 (en) | 2012-05-08 | 2016-02-23 | Cellix Bio Private Limited | Compositions and methods for the treatment of parkinson's disease |
US9346742B2 (en) | 2012-05-10 | 2016-05-24 | Cellix Bio Private Limited | Compositions and methods for the treatment of fibromyalgia pain |
WO2013168012A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of respiratory disorders |
US9321775B2 (en) | 2012-05-10 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of moderate to severe pain |
US9233161B2 (en) | 2012-05-10 | 2016-01-12 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological conditions |
WO2013168033A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for treatment of neurologic diseases |
US9315478B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9315461B2 (en) | 2012-05-10 | 2016-04-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurologic diseases |
WO2013168011A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of chronic pain |
WO2013168000A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of severe pain |
US9394288B2 (en) | 2012-05-10 | 2016-07-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of asthma and allergy |
US9499527B2 (en) | 2012-05-10 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of familial amyloid polyneuropathy |
WO2013168016A1 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of metabolic syndrome |
WO2013168005A2 (en) | 2012-05-10 | 2013-11-14 | Mahesh Kandula | Compositions and methods for the treatment of restless leg syndrome and fibromyalgia |
WO2013175344A2 (en) | 2012-05-23 | 2013-11-28 | Mahesh Kandula | Compositions and methods for the treatment of periodontitis and rheumatoid arthritis |
US9227974B2 (en) | 2012-05-23 | 2016-01-05 | Cellex Bio Private Limited | Compositions and methods for the treatment of respiratory disorders |
EP2852571A4 (en) | 2012-05-23 | 2015-11-25 | Cellix Bio Private Ltd | COMPOSITIONS AND METHOD FOR THE TREATMENT OF MUCOSITIS |
US9498461B2 (en) | 2012-05-23 | 2016-11-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
US9492409B2 (en) | 2012-05-23 | 2016-11-15 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
SG11201407322QA (en) | 2012-05-23 | 2014-12-30 | Cellix Bio Private Ltd | Compositions and methods for the treatment of multiple sclerosis |
US9108942B1 (en) | 2014-11-05 | 2015-08-18 | Mahesh Kandula | Compositions and methods for the treatment of moderate to severe pain |
US9187427B2 (en) | 2012-08-03 | 2015-11-17 | Cellix Bio Private Limited | N-substituted nicotinamide compounds and compositions for the treatment migraine and neurologic diseases |
WO2014037833A2 (en) | 2012-09-06 | 2014-03-13 | Mahesh Kandula | Compositions and methods for the treatment inflammation and lipid disorders |
JP2015529218A (ja) | 2012-09-08 | 2015-10-05 | セリックスビオ プライヴェート リミテッド | 炎症と脂質障害の治療のための組成物及び方法 |
US9333187B1 (en) | 2013-05-15 | 2016-05-10 | Cellix Bio Private Limited | Compositions and methods for the treatment of inflammatory bowel disease |
EP3004049B1 (en) | 2013-06-04 | 2018-09-05 | Cellixbio Private Limited | Compositions and methods for the treatment of diabetes and pre-diabetes |
US9096537B1 (en) | 2014-12-31 | 2015-08-04 | Mahesh Kandula | Compositions and methods for the treatment of mucositis |
CN104974061B (zh) * | 2014-04-14 | 2017-11-14 | 辽宁省药物研究院 | 一种巴柳氮钠的制备方法 |
WO2016046835A1 (en) | 2014-09-26 | 2016-03-31 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy and neurological disorders |
CN107207403A (zh) | 2014-09-29 | 2017-09-26 | 塞尔利克斯生物私人有限公司 | 用于治疗多发性硬化的组合物和方法 |
JP6564868B2 (ja) | 2014-10-27 | 2019-08-21 | セリックス バイオ プライヴェート リミテッドCellix Bio Private Limited | 多発性硬化症の治療のための、フマル酸モノメチルエステルとピペラジン又はエチレンジアミンとの3つの成分の塩 |
US10208014B2 (en) | 2014-11-05 | 2019-02-19 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological disorders |
US9173877B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of local pain |
US9175008B1 (en) | 2014-11-05 | 2015-11-03 | Cellix Bio Private Limited | Prodrugs of anti-platelet agents |
US9150557B1 (en) | 2014-11-05 | 2015-10-06 | Cellix Bio Private Limited | Compositions and methods for the treatment of hyperglycemia |
US9290486B1 (en) | 2014-11-05 | 2016-03-22 | Cellix Bio Private Limited | Compositions and methods for the treatment of epilepsy |
US9321716B1 (en) | 2014-11-05 | 2016-04-26 | Cellix Bio Private Limited | Compositions and methods for the treatment of metabolic syndrome |
US9284287B1 (en) | 2014-11-05 | 2016-03-15 | Cellix Bio Private Limited | Compositions and methods for the suppression of carbonic anhydrase activity |
US9932294B2 (en) | 2014-12-01 | 2018-04-03 | Cellix Bio Private Limited | Compositions and methods for the treatment of multiple sclerosis |
US9206111B1 (en) | 2014-12-17 | 2015-12-08 | Cellix Bio Private Limited | Compositions and methods for the treatment of neurological diseases |
EP3242869B1 (en) | 2015-01-06 | 2021-10-27 | Cellixbio Private Limited | Compositions and methods for the treatment of inflammation and pain |
CN110003044A (zh) * | 2019-04-26 | 2019-07-12 | 赤峰蒙欣药业有限公司 | 一种巴柳氮钠的制备方法 |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4045429A (en) * | 1970-03-06 | 1977-08-30 | Pharmacia Aktiebolag | 4-(4-Hydroxy- or acetoxy-3-carbomethoxyphenylazo)-benzenesulphonyl chloride |
SE353537B (ja) * | 1970-03-06 | 1973-02-05 | Pharmacia Ab | |
BE791889A (fr) * | 1971-11-26 | 1973-05-24 | Pharmacia Ab | Nouveaux derives de la pyridine |
FR2212391B1 (ja) * | 1972-12-28 | 1976-06-04 | Ugine Kuhlmann |
-
1981
- 1981-07-08 US US06/281,504 patent/US4412992A/en not_active Expired - Lifetime
- 1981-07-10 IT IT22859/81A patent/IT1138450B/it active Protection Beyond IP Right Term
- 1981-07-16 JP JP56111534A patent/JPS5753449A/ja active Granted
- 1981-07-21 DE DE19813128819 patent/DE3128819A1/de active Granted
- 1981-07-21 FR FR8114505A patent/FR2493312A1/fr active Granted
-
1985
- 1985-01-26 SG SG68/85A patent/SG6885G/en unknown
- 1985-04-25 HK HK318/85A patent/HK31885A/xx not_active IP Right Cessation
-
1986
- 1986-12-30 MY MY29/86A patent/MY8600029A/xx unknown
Cited By (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPH02242915A (ja) * | 1988-12-09 | 1990-09-27 | Hoechst Celanese Corp | 改良されたポリエステルコポリマー繊維及びその製造方法 |
JP2004507521A (ja) * | 2000-08-29 | 2004-03-11 | ノベックス・コーポレイション | 抗炎症活性および抗生物質活性を有する5−asa誘導体およびこれを用いて疾患を治療する方法 |
US9192616B2 (en) | 2005-08-24 | 2015-11-24 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
JP2010509326A (ja) * | 2006-11-03 | 2010-03-25 | サリックス ファーマシューティカルズ, インコーポレイテッド | 2−ヒドロキシ−5−フェニル安息香酸誘導体の処方および使用 |
JP2013032395A (ja) * | 2006-11-03 | 2013-02-14 | Salix Pharmaceuticals Inc | 2−ヒドロキシ−5−フェニル安息香酸誘導体の処方および使用 |
US8921344B2 (en) | 2006-11-03 | 2014-12-30 | Salix Pharmaceuticals, Inc. | Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives |
Also Published As
Publication number | Publication date |
---|---|
JPS6225656B2 (ja) | 1987-06-04 |
DE3128819C2 (ja) | 1990-02-15 |
FR2493312A1 (fr) | 1982-05-07 |
US4412992A (en) | 1983-11-01 |
DE3128819A1 (de) | 1982-04-15 |
FR2493312B1 (ja) | 1984-09-21 |
IT8122859A0 (it) | 1981-07-10 |
IT1138450B (it) | 1986-09-17 |
HK31885A (en) | 1985-05-03 |
MY8600029A (en) | 1986-12-31 |
SG6885G (en) | 1985-06-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPS5753449A (en) | 2-hydroxy-5-phenylazobenzoic acid derivative, manufacture and medicinal composition | |
JPS5777616A (en) | Medicinal composition and manufacture | |
JPS57145844A (en) | Benzoic acid derivatives, manufacture and medicinal blend | |
JPS57116030A (en) | 2-phenylethanol amine derivative, manufacture and medicinal composition | |
JPS5798281A (en) | Azabicyclooctane-carboxylic acid, manufacture and pharmaceutical composition containing same | |
JPS5764669A (en) | Novel indole derivative, manufacture and medicinal composition containing same | |
JPS5711949A (en) | Arylethanolamine derivatives,manufacture and medicinal composition containing them | |
JPS57109774A (en) | 2-substituted benzfuran derivative, manufacture and medicinal composition containing same | |
IL68323A0 (en) | Phenoxyalkylcarboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them | |
JPS5785383A (en) | Benzofuranylethanol amine derivative, manufacture and medicinal composition containing same | |
IL62912A0 (en) | Penam-3-carboxylic acid derivatives,their manufacture and pharmaceutical compositions containing them | |
JPS57131744A (en) | Substituted phenoxycinnamic acid derivative, manufacture and use | |
JPS6452763A (en) | Novel heterocyclic derivative, manufacture and medicinal composition | |
JPS5775976A (en) | Novel heterocyclic derivative, manufacture and medicinal composition containing same | |
JPS56164191A (en) | Theophyllinylmethyldioxolane derivative, its manufacture and medicine | |
IL62167A0 (en) | Phenoxy-aminopropanol derivatives,their manufacture and pharmaceutical compositions containing them | |
IL63145A (en) | Imidazothienopyrimidinedione derivatives,their manufacture and pharmaceutical compositions containing them | |
JPS5750990A (en) | Condensed as-triazine derivative, manufacture and medicinal composition containing same | |
JPS5781493A (en) | Ammoniomethyl compound, manufacture and medicinal composition containing same | |
JPS5775975A (en) | Heterocyclic derivative, manufacture and medicinal composition containing same | |
IL62592A (en) | Octahydrophenyl-quinolizine derivatives,their manufacture and pharmaceutical compositions containing them | |
JPS56127330A (en) | Novel propanoic acid derivative, manufacture and medicinal composition | |
JPS56139479A (en) | Quinoline derivative, manufacture and medicinal composition containing same | |
JPS56139482A (en) | 3-chloro-quinoline derivative, manufacture and medicinal composition | |
IL63917A0 (en) | 2-aminoimidazoles,their manufacture and pharmaceutical compositions containing them |